You are here » Home » Markets » Mutual Funds

Tata India Pharma & Healthcare Fund - Direct (D)RI

Fund Class : Equity - Pharma
Fund House : Tata Mutual Fund
Aum(Rs Cr) : 184.69
NAV 22 May 2020 11.85 0.04
(0.34%)

NAV High-Low (in Rs)

ONE Mth 219.68
219.68
52-WEEk 152.64
219.68

Trailing Returns

% 1-week 1-Mth 6-Mths 1-Yr 3-Yrs
Schemes 2.54 2.41 20.14 27.68 -
Sensex 1.37 -2.29 -25.02 -22.38 -1.35
Nifty 1.69 -1.37 -24.99 -23.77 -5.9

Competitors of Tata India Pharma & Healthcare Fund - Direct (D)RI fund

Schemes FUND
SIZE()
1-Wk
(%)
1-Mth
(%)
3-Mth
(%)
6-Mth
(%)
1-Yr
(%)
SBI Equity Minimum Variance - Regular (D) 44.93 1.98 3.42 -16.15 -13.55 -13.19
› More

Fund Features

Types of Scheme Dividend
Options Equity
Assets Size (Rs in Cr) 184.69 (31 Oct 18)
Inception Date 04 Dec 15
Fund Manager Meeta Shetty

Investment Details

Minimum Investment 5000.00
Purchase Redemption DAILY
Last Dividend paid (Rs)
Entry Load 0.00%
EXIT Load 0.00.

Fund Activity

   As On 30 Apr 2020
Category Share (%)
Equity 95.21
Reverse Repo 5.20
› More
   As On 30 Apr 2020
Sector Name Amount
Healthcare 10.23
NA 5.20
Pharmaceuticals - Indian - Bulk Drugs 20.39
Pharmaceuticals - Indian - Bulk Drugs & Formln 51.79
Pharmaceuticals - Multinational 12.80
› More
   As On 30 Apr 2020
Company Name
Dr Reddy's Labs 15.95
Sun Pharma.Inds. 15.22
Divi's Lab. 10.88
Lupin 9.51
Ipca Labs. 7.00
Abbott India 7.00
Proc. Gam. Heal. 5.11
Narayana Hrudaya 4.87
› More

Fund DETAILS

Asset Management Co.

Registered Address

Tata Asset Management Ltd,

1903 B-Wing Parinee Crescenzo
G-Block Bandra Kurla Complex
Bandra East Mumbai - 400051

Phone: 6657 8282. | Fax: 2261 3782.

Email: service@tataamc.com

Website: www.tatamutualfund.com